prevention study inclusion criteria: 1. capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; 2. men and women ≥ 19 years of age unless local laws dictate otherwise; 3. english speaking; 4. must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. 5. be symptom-free at screening/baseline. 6. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study

prevention study inclusion criteria: 1. capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; 2. men and women ≥ 19 years of age unless local laws dictate otherwise; 3. english speaking; 4. must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. 5. be symptom-free at screening/baseline. 6. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study

prevention study inclusion criteria: capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; men and women ≥ 19 years of age unless local laws dictate otherwise; english speaking; must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. be symptom-free at screening/baseline. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study

prevention study inclusion criteria: capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; men and women ≥ 19 years of age unless local laws dictate otherwise; english speaking; must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. be symptom-free at screening/baseline. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study

prevention study inclusion criteria: 1. capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; 2. men and women ≥ 19 years of age unless local laws dictate otherwise; 3. english speaking; 4. must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. 5. be symptom-free at screening/baseline. 6. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study

prevention study inclusion criteria: 1. capable of understanding and providing signed informed consent and ability to adhere to the requirements and restrictions of this protocol; 2. men and women ≥ 19 years of age unless local laws dictate otherwise; 3. english speaking; 4. must be willing to use an adequate form of contraception (or abstinence) from the time of the first dose with the imp until after the last dose of imp. 5. be symptom-free at screening/baseline. 6. work/live in contact with covid-19 infected patients or scheduled to work in a setting with high likelihood of contact with covid-19 infected patients. prevention study